Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,383 | 1,584 | 2,624 | 612 | 579 |
| Marketable Securities | 1,656 | 2,794 | 3,305 | 1,507 | 1,545 |
| Receivables | 649 | 1,664 | 980 | 2,925 | 3,436 |
| Inventories | 677 | 1,389 | 1,138 | 978 | 1,522 |
| Other current assets | 83 | 0 | 0 | 0 | 68 |
| TOTAL | $5,449 | $7,430 | $8,047 | $6,022 | $7,150 |
| Non-Current Assets | |||||
| PPE Net | 1,599 | 1,523 | 1,512 | 1,512 | 1,634 |
| Investments And Advances | 2,028 | 1,265 | 1,700 | 1,151 | 749 |
| Other Non-Current Assets | 178 | 215 | 142 | 56 | 41 |
| TOTAL | $3,804 | $3,003 | $3,353 | $2,718 | $2,425 |
| Total Assets | $9,253 | $10,434 | $11,400 | $8,740 | $9,574 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 404 | 1,787 | 1,583 | 1,964 | 2,084 |
| Other current liabilities | 50 | 17 | 13 | N/A | N/A |
| TOTAL | $521 | $1,951 | $1,631 | $2,004 | $2,329 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 77 |
| Other Non-Current Liabilities | 117 | 160 | 99 | 40 | 25 |
| TOTAL | $117 | $160 | $111 | $71 | $66 |
| Total Liabilities | $638 | $2,111 | $1,742 | $2,075 | $2,395 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,417 | 17,968 | 1,767 | 1,447 | 1,426 |
| Common Shares | 20,175 | 17,332 | 17,191 | 10,930 | 10,780 |
| Retained earnings | -6,427 | -3,443 | -1,844 | 1,156 | 1,512 |
| Other shareholders' equity | -121 | -555 | -677 | -409 | -100 |
| TOTAL | $8,615 | $8,323 | $9,658 | $6,665 | $7,180 |
| Total Liabilities And Equity | $9,253 | $10,434 | $11,400 | $8,740 | $9,574 |